Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03764007 · ClinicalTrials.gov registry record · Phase 2
18F-Fluorocholine for the Detection of Parathyroid Adenomas
A Phase 2 study, sponsored by Thomas Hope.
- Completed
- Registry status
- Phase 2
- Development phase
- 98
- Enrollment target
NCT03764007 is a Phase 2 study that has completed, run by Thomas Hope. The registered enrollment target is 98 participants.
The verdict
NCT03764007, a Phase 2 study, has completed, sponsored by Thomas Hope.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 98 participants
- Enrollment target
Study Summary
The investigators are studying the ability of F18 labeled fluorocholine PET to localize parathyroid adenomas in patients with hyperparathyroidism prior to surgery.
Interventions
- PROCEDURE Positron Emission Tomography (PET)
- DRUG 18F-Fluorocholine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2016-09-21 |
| Est. Completion | 2021-05-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03764007
The ClinicalTrials.gov registry entry for NCT03764007 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Hope, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Positron Emission Tomography (PET) is the first listed.
NCT03764007 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03764007 about?
NCT03764007 is a clinical study titled "18F-Fluorocholine for the Detection of Parathyroid Adenomas". The investigators are studying the ability of F18 labeled fluorocholine PET to localize parathyroid adenomas in patients with hyperparathyroidism prior to surgery.
What is the current status of trial NCT03764007?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 98 participants. The study started on 2016-09-21. Estimated completion is 2021-05-31.
What interventions are being tested in trial NCT03764007?
The interventions under investigation include: Positron Emission Tomography (PET) (PROCEDURE), 18F-Fluorocholine (DRUG).
Who is sponsoring clinical trial NCT03764007?
This trial is sponsored by Thomas Hope, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.